Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130190 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation of Adenomyosis
A NA study of Adenomyosis, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05130190 is a NA study of Adenomyosis that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05130190, a NA study of Adenomyosis, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
To observe the effects of radiofrequency ablation on adenomyosis through the pathological analysis of treated tissue that has been removed during planned hysterectomy.
Conditions Studied
Interventions
- DEVICE RF Treatment
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2025-01-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05130190
The ClinicalTrials.gov registry entry for NCT05130190 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adenomyosis appearing as the primary indexed condition, and to 1 intervention - of which RF Treatment is the first listed.
NCT05130190 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05130190 about?
NCT05130190 is a clinical study titled "Radiofrequency Ablation of Adenomyosis". To observe the effects of radiofrequency ablation on adenomyosis through the pathological analysis of treated tissue that has been removed during planned hysterectomy.
What is the current status of trial NCT05130190?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-07-14. Estimated completion is 2025-01-22.
What conditions does trial NCT05130190 study?
This clinical trial studies the following conditions: Adenomyosis.
What interventions are being tested in trial NCT05130190?
The interventions under investigation include: RF Treatment (DEVICE).
Who is sponsoring clinical trial NCT05130190?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05130190 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenomyosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.